H. Ogiwara

发表

TCR Repertoire Analysis Reveals Mobilization of Novel CD8+ T Cell Clones Into the Cancer-Immunity Cycle Following Anti-CD4 Antibody Administration

K. Matsushima, S. Hashimoto, S. Ueha, 2019, Front. Immunol..

Clonal spreading of tumor-infiltrating T cells underlies the robust antitumor immune responses

T. Abe, K. Matsushima, S. Ueha, 2022, bioRxiv.

Combined treatment with HMGN1 and anti-CD4 depleting antibody reverses T cell exhaustion and exerts robust anti-tumor effects in mice

K. Matsushima, S. Ueha, S. Shichino, 2019, Journal of Immunotherapy for Cancer.

Anti-inflammatory effect of chlorogenic acid on the IL-8 production in Caco-2 cells and the dextran sulphate sodium-induced colitis symptoms in C57BL/6 mice.

M. Totsuka, Zhaohui Zhao, M. Shimizu, 2015, Food chemistry.

6-shogaol, a major compound in ginger, induces aryl hydrocarbon receptor-mediated transcriptional activity and gene expression.

T. Inakuma, T. Yakabe, M. Shimizu, 2014, Journal of agricultural and food chemistry.

Establishment of a stable aryl hydrocarbon receptor-responsive HepG2 cell line

T. Inakuma, M. Shimizu, H. Ogiwara, 2015, Cytotechnology.

Human thioredoxin/adult T cell leukemia-derived factor activates the enhancer binding protein of human immunodeficiency virus type 1 by thiol redox control mechanism.

J. Yodoi, T. Okamoto, H. Ogiwara, 1992, International immunology.

First-in-human phase 1 study of IT1208, a defucosylated humanized anti-CD4 depleting antibody, in patients with advanced solid tumors

S. Nomura, A. Sato, K. Matsushima, 2019, Journal of Immunotherapy for Cancer.

Histopathological evaluation of the diversity of cells susceptible to H5N1 virulent avian influenza virus.

F. Shibasaki, M. Kohara, K. Munekata, 2014, The American journal of pathology.

Induction of NAD(P)H:quinone oxidoreductase 1 expression by cysteine via Nrf2 activation in human intestinal epithelial LS180 cells

M. Shimizu, H. Ogiwara, H. Satsu, 2012, Amino Acids.

Combining an alarmin HMGN1 peptide with PD-L1 blockade facilitates stem-like CD8+ T cell expansion and results in robust antitumor effects

K. Matsushima, S. Ueha, S. Shichino, 2020, bioRxiv.

Combining an Alarmin HMGN1 Peptide with PD-L1 Blockade Results in Robust Antitumor Effects with a Concomitant Increase of Stem-Like/Progenitor Exhausted CD8+ T Cells

K. Matsushima, S. Ueha, S. Shichino, 2021, Cancer Immunology Research.

Robust Antitumor Effects of Combined Anti–CD4-Depleting Antibody and Anti–PD-1/PD-L1 Immune Checkpoint Antibody Treatment in Mice

K. Matsushima, S. Ueha, K. Kakimi, 2015, Cancer Immunology Research.

Transient Depletion of CD4+ Cells Induces Remodeling of the TCR Repertoire in Gastrointestinal Cancer

K. Matsushima, M. Yamashita, M. Kurachi, 2021, Cancer Immunology Research.

Induction of NAD(P)H:quinone oxidoreductase 1 expression by cysteine via Nrf2 activation in human intestinal epithelial LS180 cells

H. Ogiwara, H. Satsu, Yuto Hiura, 2012, Amino Acids.

Robust Antitumor Effects of Combined Anti–CD4-Depleting Antibody and Anti–PD-1/PD-L1 Immune Checkpoint Antibody Treatment in Mice

K. Matsushima, S. Ueha, K. Kakimi, 2015, Cancer Immunology Research.

Robust antitumor effects of combined anti-CD4-depleting antibody and anti-PD-1/PD-L1 1 immune checkpoint antibody treatment in mice

K. Matsushima, S. Ueha, K. Kakimi, 2015 .